Literature DB >> 9117087

Antagonist inhibition curves and the measurement of dissociation constants.

R B Barlow1, S M Bond, E Bream, L Macfarlane, D S McQueen.   

Abstract

1. Experiments carried out on guinea-pig isolated ileum with carbachol as agonist and diphenyl-acetoxyethyl-dimethyl-ethyl-ammonium (DADMEA) bromide as antagonist gave results which fit the theoretical relation between fractional inhibition (Q) of the effects of an agonist ([A]) and the concentration of a competitive antagonist ([B]): this also involves the Hill coefficient (logistic slope factor, P) for the agonist concentration-response curve and the degree of agonist stimulation, [A]/[A]50, where [A]50 produces a half-maximum response. 2. Values of IC50 and an exponent, P', can be obtained by fitting Q to [B] using a logistic approximation to the relation. Both P' and IC50 should be greater with higher agonist stimulation but the increase in P' may be masked by errors in extreme values of Q. Estimates of IC50, however, invariably increased with higher agonist stimulation but with a steep concentration-response curve (P > 1) and low agonist stimulation ([A]/[A]50 < 1, IC50 can be less than KD. 3. KD was calculated from the results in three ways; (i) by a least-squares fit of Q to [B] using the values of P and [A]/[A]50 calculated from the control concentration-response curve; (ii) from the value of IC50 for each line and the values of P and [A]/[A]50 and (iii) by using the agonist concentration-response curve to calculate the dose-ratio and estimate of KD for each in the presence of the antagonist. The methods gave similar results (nM: 11 experiments), 12.4 +/- 1.1 (i), 11.7 +/- 0.9 (ii), 14.8 +/- 1.6 (iii) but there are advantages in using methods (i) or (ii) rather than (iii). 4. The method by which KD is calculated is less important than the experimental design: the plan used in this work, with alternative small and large responses from the tissue, is very suitable for estimating KD with low concentrations of antagonists and small dose-ratios. Although it is not a sensitive test for competitive behaviour because only a small range of concentrations of antagonist is tested, the estimate of affinity should be free from complications involved in the use of higher concentrations of antagonist (and agonist) and the nature of the antagonism can always be checked by doing further experiments in the presence of a known competitive antagonist.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117087      PMCID: PMC1564343          DOI: 10.1038/sj.bjp.0700865

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  5 in total

1.  Relationships between inhibition constants, inhibitor concentrations for 50% inhibition and types of inhibition: new ways of analysing data.

Authors:  A Cortés; M Cascante; M L Cárdenas; A Cornish-Bowden
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

2.  Analysis of ligand-receptor interactions from the molecular level to the whole-body level.

Authors:  B N Manukhin
Journal:  Neurosci Behav Physiol       Date:  2002 May-Jun

3.  New compstatin variants through two de novo protein design frameworks.

Authors:  M L Bellows; H K Fung; M S Taylor; C A Floudas; A López de Victoria; D Morikis
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

4.  The molecular interaction of the high affinity reversal agent XR9576 with P-glycoprotein.

Authors:  C Martin; G Berridge; P Mistry; C Higgins; P Charlton; R Callaghan
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

5.  Effects of arginine 10 to lysine substitution on ω-conotoxin CVIE and CVIF block of Cav2.2 channels.

Authors:  G Berecki; N L Daly; Y H Huang; S Vink; D J Craik; P F Alewood; D J Adams
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.